Clearance Summary
ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT received FDA 510(k) clearance under submission number K131515, sponsored by Alfa Wassermann. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2013-08-14.
- Submission: K131515
- Applicant / Sponsor: Alfa Wassermann
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1700
- Decision date: 2013-08-14
Classification & Regulation
This clearance is catalogued under FDA product code KLI and 21 CFR 862.1700, within the Clinical Chemistry review panel as a Class II device.